calendar
44 catalysts · 44 phase 2 completion · 33 phase 1 completion · 24 phase 1 2 completion · 21 phase 2 initiation · 17 phase 1 initiation · 13 phase 1 2 initiation
next 91 dayslessmore
MonWedFri
44 catalysts · 44 phase 2 completion · 33 phase 1 completion · 24 phase 1 2 completion · 21 phase 2 initiation · 17 phase 1 initiation · 13 phase 1 2 initiation
Therapy area: Oncology. Indication: Colorectal Cancer, Metastatic Colorectal Cancer
Therapy area: Oncology. Indication: Rectal Cancer
Therapy area: Oncology. Indication: Bile Duct Cancer (Cholangiocarcinoma)
Therapy area: Oncology. Indication: Rectal Cancer
Therapy area: Oncology. Indication: B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Therapy area: Oncology. Indication: Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC)
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease)
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Squamous Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Pancreatic Cancer
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Therapy area: Cardiovascular. Indication: Pulmonary Arterial Hypertension
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Plasma Cell Neoplasm, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Oncology. Indication: Malignant Neoplasms
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Adenocarcinoma, Colon Cancer, Colorectal Cancer
Therapy area: Oncology. Indication: Breast Cancer, Castration-Resistant Prostate Cancer (CRPC), Epithelial Ovarian Cancer, Fallopian Tube Cancer, Metastatic Breast Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Peritoneal Cancer, Solid Tumor
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Gliosarcoma
Therapy area: Oncology. Indication: Colorectal Cancer, Metastatic Colorectal Cancer
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer
Therapy area: Cardiovascular. Indication: Idiopathic (Essential) Hypertension
Therapy area: Oncology. Indication: Lung Adenocarcinoma, Non-Small Cell Lung Cancer
Therapy area: Cardiovascular, Other Diseases. Indication: Hemorrhagic Shock, Injury, Trauma
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Therapy area: Oncology. Indication: Triple-Negative Breast Cancer (TNBC)
Therapy area: Cardiovascular, Oncology. Indication: Hepatocellular Carcinoma, Thrombosis, Venous (Vein) Thrombosis
Therapy area: Cardiovascular, Oncology. Indication: Diffuse Large B-Cell Lymphoma, Hematological Tumor, Leukemia, Lymphoma, Multiple Myeloma (Kahler Disease), Myeloproliferative Disorders, Pulmonary Embolism, Thromboembolic Disease, Venous Thromboembolism
Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke, Cerebral Infarction (Brain Infarction)
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Triple-Negative Breast Cancer (TNBC)
Therapy area: Cardiovascular. Indication: Hypotension
Therapy area: Cardiovascular, Genito Urinary System, Infectious Disease. Indication: Acute Renal Failure (ARF) (Acute Kidney Injury), Sepsis, Septic Shock
Therapy area: Cardiovascular. Indication: Myocardial Infarction
Therapy area: Oncology. Indication: Mesenchymal Tumor
Therapy area: Oncology. Indication: Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Metastatic Breast Cancer, Triple-Negative Breast Cancer (TNBC)
Therapy area: Oncology. Indication: Lung Cancer
Therapy area: Oncology. Indication: Endometrial Cancer
Therapy area: Oncology. Indication: Kidney Cancer (Renal Cell Cancer), Metastatic Renal Cell Carcinoma
Therapy area: Oncology. Indication: Soft Tissue Sarcoma
Therapy area: Oncology. Indication: Neuroblastoma
Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke, Ischemic Stroke
Therapy area: Oncology. Indication: Prostate Cancer
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer
Therapy area: Oncology. Indication: Colorectal Cancer
Therapy area: Oncology. Indication: Small-Cell Lung Cancer